BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31751820)

  • 41. The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer.
    Yang XW; Yuan JM; Chen JY; Yang J; Gao QG; Yan XZ; Zhang BH; Feng S; Wu MC
    BMC Cancer; 2014 Sep; 14():652. PubMed ID: 25187159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent.
    Yang XW; Yang J; Li L; Man XB; Zhang BH; Shen F; Wu MC
    PLoS One; 2012; 7(12):e51513. PubMed ID: 23300551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognosis after curative resection of gallbladder cancer with hilar invasion is similar to that of hilar cholangiocarcinoma.
    Nasu Y; Tanaka E; Hirano S; Tsuchikawa T; Kato K; Matsumoto J; Shichinohe T; Kondo S
    J Hepatobiliary Pancreat Sci; 2012 May; 19(3):274-80. PubMed ID: 21879321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA aberrations: An emerging field for gallbladder cancer management.
    Chandra V; Kim JJ; Mittal B; Rai R
    World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer.
    Baghel K; Kazmi HR; Chandra A; Raj S; Srivastava RN
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e120-e125. PubMed ID: 30740890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer.
    Lu W; Gao J; Yang J; Cao Y; Jiang L; Li M; Zhang Y; Zhou J; Liu Y
    Medicine (Baltimore); 2015 Dec; 94(49):e2244. PubMed ID: 26656369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Laparoscopic and Open Approach in Treating Gallbladder Cancer.
    Feng JW; Yang XH; Liu CW; Wu BQ; Sun DL; Chen XM; Jiang Y; Qu Z
    J Surg Res; 2019 Feb; 234():269-276. PubMed ID: 30527484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma.
    Lv YP; Shi W; Liu HX; Kong XJ; Dai DL
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):518-522. PubMed ID: 28239818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
    Golob-Schwarzl N; Wodlej C; Kleinegger F; Gogg-Kamerer M; Birkl-Toeglhofer AM; Petzold J; Aigelsreiter A; Thalhammer M; Park YN; Haybaeck J
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2699-2711. PubMed ID: 31586263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
    Shu GS; Lv F; Yang ZL; Miao XY
    Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis.
    Hu Y; Ma Y; Liu J; Cai Y; Zhang M; Fang X
    BMC Cancer; 2019 Nov; 19(1):1157. PubMed ID: 31779593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgical approaches to advanced gallbladder cancer : a 40-year single-institution study of prognostic factors and resectability.
    Higuchi R; Ota T; Araida T; Kajiyama H; Yazawa T; Furukawa T; Yoshikawa T; Takasaki K; Yamamoto M
    Ann Surg Oncol; 2014 Dec; 21(13):4308-16. PubMed ID: 25023547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance.
    Cai W; Li Q; Yang Z; Miao X; Wen Y; Huang S; Ouyang J
    Clin Transl Oncol; 2013 Oct; 15(10):818-24. PubMed ID: 23475628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
    Yuan LW; Liu DC; Yang ZL
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.
    Xu WY; Zhang HH; Yang XB; Bai Y; Lin JZ; Long JY; Xiong JP; Zhang JW; Sang XT; Zhao HT
    World J Gastroenterol; 2018 Apr; 24(13):1451-1463. PubMed ID: 29632426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients.
    Lim H; Seo DW; Park DH; Lee SS; Lee SK; Kim MH; Hwang S
    J Clin Gastroenterol; 2013; 47(5):443-8. PubMed ID: 23188077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of the Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis.
    Mochizuki T; Abe T; Amano H; Hanada K; Hattori M; Kobayashi T; Nakahara M; Ohdan H; Noriyuki T
    Ann Surg Oncol; 2018 Jun; 25(6):1699-1708. PubMed ID: 29626304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.